Genexine, Inc. (KOSDAQ:095700)
South Korea · Delayed Price · Currency is KRW 5,040.00
+45.00 (0.90%)
At close: Dec 5, 2025
Genexine Market Cap
Genexine has a market cap or net worth of 229.22 billion as of December 5, 2025. Its market cap has decreased by -27.48% in one year.
Market Cap
229.22B
Enterprise Value
n/a
Revenue
5.81B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,040.00
Market Cap Chart
Since September 15, 2009, Genexine's market cap has increased from 109.02B to 229.22B, an increase of 110.25%. That is a compound annual growth rate of 4.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 229.22B | -5.62% |
| Dec 30, 2024 | 242.86B | -40.82% |
| Dec 28, 2023 | 410.35B | -12.73% |
| Dec 29, 2022 | 470.21B | -67.78% |
| Dec 30, 2021 | 1.46T | -52.47% |
| Dec 30, 2020 | 3.07T | 106.72% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 40.30T |
| ALTEOGEN | 27.86T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.53T |
| Yuhan | 8.91T |
| LigaChem Biosciences | 6.91T |
| Peptron | 6.67T |